Bezafibrate, a peroxisome proliferator-activated receptor α agonist, decreases circulating CD14+CD16+ monocytes in patients with type 2 diabetes

Translational Research

Volumn 165, Issue 2, 2015, Pages 336-345

  Terasawa, Tomoko ^a   Aso, Yoshimasa ^a   Omori, Kyoko ^a   Fukushima, Maiko ^a   Momobayashi, Atsushi ^a   Inukai, Toshihiko ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BEZAFIBRATE; C REACTIVE PROTEIN; CD16 ANTIGEN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 1BETA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; RNA; TRIACYLGLYCEROL; AUTACOID; CD14 ANTIGEN; CYTOKINE; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CD14+ CD16+ MONOCYTE; CELL ISOLATION; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; IN VITRO STUDY; MALE; MONOCYTE; MONONUCLEAR CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; AGONISTS; BLOOD; CLASSIFICATION; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FEMALE; GENE EXPRESSION; GENETICS; GLUCOSE INTOLERANCE; IMMUNOLOGY; METABOLISM; MIDDLE AGED; TRANSLATIONAL RESEARCH;

ADULT; ANTIGENS, CD14; BEZAFIBRATE; CROSS-SECTIONAL STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; GLUCOSE INTOLERANCE; GPI-LINKED PROTEINS; HUMANS; INFLAMMATION MEDIATORS; MALE; MIDDLE AGED; MONOCYTES; PPAR ALPHA; RECEPTORS, IGG; RNA, MESSENGER; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84921374185     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.07.008     Document Type: Article

References (19)

1. K. Ley, Y.I. Miller, and C.C. Hedrick Monocyte and macrophage dynamics during atherogenesis Arterioscler Thromb Vasc Biol 31 2011 1506 1516
2. B. Passlick, D. Flieger, and H.W. Ziegler-Heitbrock Identification and characterization of a novel monocyte subpopulation in human peripheral blood Blood 74 1989 2527 2534
3. K.U. Belge, F. Dayyani, and A. Horelt The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF J Immunol 168 2002 3536 3542
4. F. Geissmann, S. Jung, and D.R. Littman Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 19 2003 71 82
5. U. Sester, M. Sester, G. Heine, H. Kaul, M. Girndt, and H. Köhler Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment Nephrol Dial Transplant 16 2001 1402 1408
6. A. Schlitt, G.H. Heine, and S. Blankenberg CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels Thromb Haemost 92 2004 419 424
7. B.M. Forman, J. Chen, and R.M. Evans Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta Proc Natl Acad Sci U S A 94 1997 4312 4317
8. A. Zambon, P. Gervois, P. Pauletto, J.C. Fruchart, and B. Staels Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence Arterioscler Thromb Vasc Biol 26 2006 977 986
9. T. Nakamachi, T. Nomiyama, and F. Gizard PPARalpha agonists suppress osteopontin expression in macrophages and decrease plasma levels in patients with type 2 diabetes Diabetes 56 2007 1662 1670
10. G. Chinetti, S. Griglio, and M. Antonucci Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages J Biol Chem 273 1998 25573 25580
11. M. Frankenberger, T. Sternsdorf, H. Pechumer, A. Pforte, and H.W. Ziegler-Heitbrock Differential cytokine expression in human blood monocyte subpopulations: a polymerase chain reaction analysis Blood 87 1996 373 377
12. H. Tsujioka, T. Imanishi, and H. Ikejima Impact of heterogeneity of human peripheral blood monocyte subsets on myocardial salvage in patients with primary acute myocardial infarction J Am Coll Cardiol 54 2009 130 138
13. K.S. Rogacev, S. Seiler, and A.M. Zawada CD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney disease Eur Heart J 32 2011 84 92
14. C. Poitou, E. Dalmas, and M. Renovato CD14dimCD16+ and CD14+CD16+ monocytes in obesity and during weight loss: relationships with fat mass and subclinical atherosclerosis Arterioscler Thromb Vasc Biol 31 2011 2322 2330
15. K.L. Timmerman, M.G. Flynn, P.M. Coen, M.M. Markofski, and B.D. Pence Exercise training-induced lowering of inflammatory (CD14+CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol 84 2008 1271 1278
16. P. Ancuta, L. Weiss, and N. Haeffner-Cavaillon CD14+CD16++ cells derived in vitro from peripheral blood monocytes exhibit phenotypic and functional dendritic cell-like characteristics Eur J Immunol 30 2000 1872 1883
17. G. Fingerle, A. Pforte, B. Passlick, M. Blumenstein, M. Ströbel, and H.W. Ziegler-Heitbrock The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients Blood 82 1993 3170 3176
18. P. Delerive, K. De Bosscher, and S. Besnard Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1 J Biol Chem 274 1999 32048 32054
19. S. Ramanan, M. Kooshki, W. Zhao, F.C. Hsu, and M.E. Robbins PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways Free Radic Biol Med 45 2008 1695 1704